Our top pick for
Beginners
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Tekmira Pharmaceuticals Corporation stock
Own Tekmira Pharmaceuticals Corporation stock in just a few minutes.
Tekmira Pharmaceuticals Corporation is an other business based in the US. Tekmira Pharmaceuticals Corporation shares (TKMR) are listed on the NASDAQ and all prices are listed in US Dollars.
How to buy shares in Tekmira Pharmaceuticals Corporation
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – TKMR – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Active traders
Our top pick for
Building a portfolio
Tekmira Pharmaceuticals Corporation share price
Use our graph to track the performance of TKMR stocks over time.Tekmira Pharmaceuticals Corporation shares at a glance
Information last updated 2020-10-30.
| 52-week range | $0.88 - $6.48 |
|---|---|
| 50-day moving average | $10.83 |
| 200-day moving average | $10.83 |
| Wall St. target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | N/A |
Buy Tekmira Pharmaceuticals Corporation shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Tekmira Pharmaceuticals Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Tekmira Pharmaceuticals Corporation financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | 0% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Book value | N/A |
| Market capitalisation | $156.2 million |
TTM: trailing 12 months
Tekmira Pharmaceuticals Corporation share dividends
We're not expecting Tekmira Pharmaceuticals Corporation to pay a dividend over the next 12 months.
Tekmira Pharmaceuticals Corporation overview
DELISTED - Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing ribonucleic acid (RNA) interference (RNAi) therapeutics and providing its lipid nanoparticle (LNP) delivery technology to pharmaceutical partners. On March 1, 2012, it announced that the Company had secured a license from Alnylam to develop TKMALDH2, an RNAi therapeutic that utilizes Tekmira's LNP for the treatment of Alcohol Dependence (AD). Its lead oncology product candidate, TKM-PLK1, targets PLK1, a protein involved in tumor cell proliferation and a validated oncology target. On February 8, 2012, it announced that Phase I clinical trial for TKM-Ebola had been initiated. The Phase 1 TKM-Ebola clinical trial is a placebo-controlled, single-blind, single-ascending dose study with additional multiple-ascending dose cohorts in healthy human volunteers. In the field of RNAi therapeutics, the Company has licensed its LNP delivery technology to Alnylam Pharmaceuticals, Inc. and Merck & Co.
Frequently asked questions
What is Tekmira Pharmaceuticals Corporation's ISIN number?Tekmira Pharmaceuticals Corporation's international securities identification number is: US03879J1007 What is Tekmira Pharmaceuticals Corporation's CUSIP number?
Tekmira Pharmaceuticals Corporation's Committee on Uniform Securities Identification Procedures number is: 03879J100
More guides on Finder
-
How to buy TC Bancshares (TCBC) stock when it goes public
Everything we know about the TC Bancshares IPO, plus information on how to buy in.
-
How to buy Soulgate (SSR) stock when it goes public
Everything we know about the Soulgate IPO, plus information on how to buy in.
-
How to buy Alzamend Neuro (ALZN) stock when it goes public
Everything we know about the Alzamend Neuro IPO, plus information on how to buy in.
-
How to buy Singular Genomics Systems (OMIC) stock when it goes public
Everything we know about the Singular Genomics Systems IPO, plus information on how to buy in.
-
How to buy Golden Sun Education Group Limited (GSUN) stock when it goes public
Everything we know about the Golden Sun Education Group Limited IPO, plus information on how to buy in.
-
How to buy Phillips Edison & Company (PECO) stock when it goes public
Everything we know about the Phillips Edison & Company IPO, plus information on how to buy in.
-
How to buy FIGS (FIGS) stock when it goes public
Everything we know about the FIGS IPO, plus information on how to buy in.
-
How to buy DLocal Limited (DLO) stock when it goes public
Everything we know about the DLocal Limited IPO, plus information on how to buy in.
-
How to buy Torchy’s Tacos (TKMR.US) stock when it goes public
Everything we know about the Torchy’s Tacos IPO, plus information on how to buy in.
-
How to buy Dutch Bros Coffee (TKMR.US) stock when it goes public
Everything we know about the Dutch Bros Coffee IPO, plus information on how to buy in.
Ask an Expert